[go: up one dir, main page]

PL2491021T3 - Nowe acylopiperazynony i ich zastosowanie jako środki farmaceutyczne - Google Patents

Nowe acylopiperazynony i ich zastosowanie jako środki farmaceutyczne

Info

Publication number
PL2491021T3
PL2491021T3 PL10768235T PL10768235T PL2491021T3 PL 2491021 T3 PL2491021 T3 PL 2491021T3 PL 10768235 T PL10768235 T PL 10768235T PL 10768235 T PL10768235 T PL 10768235T PL 2491021 T3 PL2491021 T3 PL 2491021T3
Authority
PL
Poland
Prior art keywords
acylpiperazinones
pharmaceuticals
novel
novel acylpiperazinones
Prior art date
Application number
PL10768235T
Other languages
English (en)
Inventor
Vincent Gerusz
Sonia Escaich
Mayalen Oxoby
Francois Moreau
Original Assignee
Fab Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fab Pharma Sas filed Critical Fab Pharma Sas
Publication of PL2491021T3 publication Critical patent/PL2491021T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL10768235T 2009-10-20 2010-10-20 Nowe acylopiperazynony i ich zastosowanie jako środki farmaceutyczne PL2491021T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25335409P 2009-10-20 2009-10-20
EP10768235.3A EP2491021B1 (en) 2009-10-20 2010-10-20 Novel acylpiperazinones and their use as pharmaceuticals
PCT/EP2010/065811 WO2011048153A1 (en) 2009-10-20 2010-10-20 Novel acylpiperazinones and their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
PL2491021T3 true PL2491021T3 (pl) 2014-10-31

Family

ID=43334342

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10768235T PL2491021T3 (pl) 2009-10-20 2010-10-20 Nowe acylopiperazynony i ich zastosowanie jako środki farmaceutyczne

Country Status (8)

Country Link
US (2) US8383621B2 (pl)
EP (1) EP2491021B1 (pl)
JP (1) JP5752138B2 (pl)
CA (1) CA2774910A1 (pl)
DK (1) DK2491021T3 (pl)
ES (1) ES2483120T3 (pl)
PL (1) PL2491021T3 (pl)
WO (1) WO2011048153A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2774910A1 (en) 2009-10-20 2011-04-28 Vincent Gerusz Novel acylpiperazinones and their use as pharmaceuticals
CN119954697A (zh) * 2018-08-24 2025-05-09 赛尼欧普罗有限责任公司 用于治疗病态状况的芳香型分子
CN116143782B (zh) * 2021-11-22 2024-04-12 西南大学 一类螺[吡咯烷-2,3'-喹啉]-2'-酮类衍生物的设计合成与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687547B2 (en) * 2004-08-23 2010-03-30 Research Foundation Of State University Of New York Diphenyl ether antimicrobial compounds
EP1845087A1 (en) * 2006-04-14 2007-10-17 Mutabilis SA Hydroxyphenyl derivatives and biological applications thereof
KR20120128594A (ko) * 2009-09-01 2012-11-27 에프에이비 파마 에스에이에스 신규의 항균성 하이드록시페닐 화합물
CA2774910A1 (en) 2009-10-20 2011-04-28 Vincent Gerusz Novel acylpiperazinones and their use as pharmaceuticals

Also Published As

Publication number Publication date
US20120232079A1 (en) 2012-09-13
EP2491021A1 (en) 2012-08-29
US8623865B2 (en) 2014-01-07
US20130137689A1 (en) 2013-05-30
EP2491021B1 (en) 2014-04-23
US8383621B2 (en) 2013-02-26
JP2013508341A (ja) 2013-03-07
JP5752138B2 (ja) 2015-07-22
ES2483120T3 (es) 2014-08-05
CA2774910A1 (en) 2011-04-28
WO2011048153A1 (en) 2011-04-28
DK2491021T3 (da) 2014-07-14

Similar Documents

Publication Publication Date Title
IL249669A0 (en) Converted 5-fluoro-1h-pyrazolopyridines and their use
ZA201202489B (en) Novel heterocyclic acrylamides and their use as pharmaceuticals
IL214911A0 (en) Solfonylated tetrahydroazolopyrazines and their use as medicinal products
SG10201506238SA (en) Heteroaryls And Uses Thereof
SI3964502T1 (sl) Spojine, ki ciljajo na PSMA, in njihove uporabe
SMT201700357T1 (it) Ariltriazoloni legati attraverso bis-arile e loro impiego
ZA201303499B (en) Specific diarylhydantoin and diarylthiohydantion compounds
GB0914644D0 (en) Novel agents and uses thereof
ZA201109034B (en) Aminopyrrolidinone derivatives and uses thereof
ZA201208173B (en) Peptices and their use
EP2627181A4 (en) HETEROARYLE AND USES THEREOF
GB0921001D0 (en) Products and uses
GB0906983D0 (en) Novel use
IL220427A (en) Tertiary history of 8-hydroxyquinoline-7-carboxamide and their use
HUE041512T2 (hu) Új kombináció és alkalmazás
GB201007202D0 (en) Product and uses
GB0902173D0 (en) Compounds and their use
GB0909768D0 (en) Novel compounds and uses thereof
GB0905864D0 (en) Novel use
PL2491021T3 (pl) Nowe acylopiperazynony i ich zastosowanie jako środki farmaceutyczne
GB0909792D0 (en) Composition and uses thereof
GB0905525D0 (en) Compounds and uses
GB0902013D0 (en) Novel compounds and their use
GB0908087D0 (en) Novel compounds and uses thereof
GB0905231D0 (en) Compounds and their use